A FEASIBILITY STUDY OF INTRA-NODAL AUTOLOGOUS DENDRITIC CELL VACCINATION FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME

被引：0

作者：

Fadul, Camilo ^{[1
]}

Szczepiorkowski, Zbignew ^{[1
]}

Rhodes, Harker ^{[2
]}

Fisher, Jan ^{[1
]}

Demidenko, Eugene ^{[3
]}

Eskey, Clifford ^{[1
]}

Harris, Robert ^{[2
]}

Kingman, Linda ^{[1
]}

Hartford, Alan ^{[1
]}

Wishart, Heather ^{[1
]}

Lewis, Lionel ^{[1
]}

Carlson, Cheryl ^{[1
]}

Webber, Susan ^{[1
]}

Fischer, Dawn ^{[2
]}

Pipas, J. Marc ^{[1
]}

Erkmenn, Kadir ^{[1
]}

Roberts, David W. ^{[1
]}

Simmons, Nathan ^{[1
]}

Barth, Richard ^{[1
]}

Ernstoff, Marc ^{[1
]}

机构：

[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA

[2] Dartmouth Coll, Lebanon, NH 03756 USA

[3] Dartmouth Coll, Hanover, NH 03755 USA

来源：

NEURO-ONCOLOGY | 2008年 / 10卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：811 / 811

页数：1

共 50 条

[31] First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau
Keyoumars Ashkan
David D. Tran
Jian L. Campian
John E. Trusheim
Charles S. Cobbs
Jason A. Heth
Michael Salacz
Sarah Taylor
Stacy D. D’Andre
Fabio M. Iwamoto
Edward J. Dropcho
Yaron A. Moshel
Kevin A. Walter
Clement P. Pillainayagam
Robert Aiken
Rekha Chaudhary
Samuel A. Goldlust
Daniela A. Bota
Paul Duic
Jai Grewal
Heinrich Elinzano
Steven A. Toms
Kevin O. Lillehei
Tom Mikkelsen
Tobias Walbert
Steven R. Abram
Andrew J. Brenner
Steven Brem
Matthew G. Ewend
Simon Khagi
Jana Portnow
Lyndon J. Kim
William G. Loudon
Reid C. Thompson
David E. Avigan
Karen L. Fink
Francois J. Geoffroy
Scott Lindhorst
Jose Lutzky
Andrew E. Sloan
Gabriele Schackert
Dietmar Krex
Hans-Jorg Meisel
Julian Wu
Raphael P. Davis
Christopher Duma
Arnold B. Etame
David Mathieu
Santosh Kesari
[J]. Journal of Translational Medicine, 16
[32] Dendritic cell vaccination in combination with TLR-7 agonist, imiquimod, following radio-chemotherapy for newly diagnosed glioblastoma
Liau, L. M.
Prins, R. M.
Odesa, S. K.
Yang, M. Y.
Lin, M. S.
Khan-Farooqi, H.
Soto, H.
Lai, A.
Bosch, M.
Boynton, A.
Cloughesy, T. F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[33] Dendritic cell vaccination in combination with TLR7 agonist imiquimod following radio-chemotherapy for newly diagnosed glioblastoma
Prins, Robert M.
Odesa, Sylvia K.
Yang, Meng-Yin
Khan-Farooqi, Haumith
Bosch, Marnix
Boynton, Alton
Cloughesy, Timothy F.
Liau, Linda M.
[J]. JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 651 - 652
[34] Prolonging the Overall Survival by Vaccination of autologous tumor lysate-loaded dendritic Cells (DCVax-L) in Patients with newly diagnosed and recurrent Glioblastoma
Deng, Maximilian Y.
Debus, Juergen
Koenig, Laila
[J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (03) : 327 - 329
[35] A FEASIBILITY STUDY OF THE NATIVIS VOYAGER® SYSTEM IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Barkhoudarian, Garni
Chowdhary, Sajeel
Blondin, Nicholas
Kesari, Santosh
[J]. NEURO-ONCOLOGY, 2018, 20 : 16 - 17
[36] FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Barkhoudarian, Garni
Blondin, Nicholas
Chowdhary, Sajeel
Fonkem, Ekokobe
Vaillant, Brian
Kesari, Santosh
[J]. NEURO-ONCOLOGY, 2019, 21 : 29 - 29
[37] PHASE I/IIA TRIAL OF AUTOLOGOUS FORMALIN-FIXED TUMOR VACCINE IN TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
Muragaki, Yoshihiro
Maruyama, Takashi
Iseki, Hiroshi
Takakura, Kintomo
Tanaka, Masahiko
Shinohara, Chie
Tsuboi, Koji
Yamamoto, Tetsuya
Matsumura, Akira
Matsutani, Masao
Karasawa, Katsuyuki
Ohno, Tadao
Hori, Tomokatsu
[J]. NEURO-ONCOLOGY, 2009, 11 (06) : 883 - 883
[38] Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma
Parney, Ian F.
Anderson, S. Keith
Gustafson, Michael P.
Steinmetz, Susan
Peterson, Timothy E.
Kroneman, Trynda N.
Raghunathan, Aditya
O'Neill, Brian P.
Buckner, Jan C.
Solseth, Mary
Dietz, Allan B.
[J]. NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
[39] Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau
Keyoumars Ashkan
David D. Tran
Jian L. Campian
John E. Trusheim
Charles S. Cobbs
Jason A. Heth
Michael Salacz
Sarah Taylor
Stacy D. D’Andre
Fabio M. Iwamoto
Edward J. Dropcho
Yaron A. Moshel
Kevin A. Walter
Clement P. Pillainayagam
Robert Aiken
Rekha Chaudhary
Samuel A. Goldlust
Daniela A. Bota
Paul Duic
Jai Grewal
Heinrich Elinzano
Steven A. Toms
Kevin O. Lillehei
Tom Mikkelsen
Tobias Walbert
Steven R. Abram
Andrew J. Brenner
Steven Brem
Matthew G. Ewend
Simon Khagi
Jana Portnow
Lyndon J. Kim
William G. Loudon
Reid C. Thompson
David E. Avigan
Karen L. Fink
Francois J. Geoffroy
Scott Lindhorst
Jose Lutzky
Andrew E. Sloan
Gabriele Schackert
Dietmar Krex
Hans-Jorg Meisel
Julian Wu
Raphael P. Davis
Christopher Duma
Arnold B. Etame
David Mathieu
Santosh Kesari
[J]. Journal of Translational Medicine, 16
[40] Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations
Chinot, OL
Barrie, M
Frauger, E
Dufour, H
Figarella-Branger, D
Palmari, J
Braguer, D
Hoang-Xuan, K
Moktari, K
Peragut, JCC
Martin, PMM
Grisoli, F
[J]. CANCER, 2004, 100 (10) : 2208 - 2214

← 1 2 3 4 5 →